PhenixFIN (PFX) Competitors $49.70 +0.30 (+0.61%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipTrends PFX vs. HQL, MIY, ASG, SAR, MHN, MIN, TPVG, AEF, MMT, and MXFShould you be buying PhenixFIN stock or one of its competitors? The main competitors of PhenixFIN include Abrdn Life Sciences Investors (HQL), BlackRock MuniYield Michigan Quality Fund (MIY), Liberty All-Star Growth Fund (ASG), Saratoga Investment (SAR), BlackRock MuniHoldings New York Quality Fund (MHN), MFS Intermediate Income Trust (MIN), TriplePoint Venture Growth BDC (TPVG), Abrdn Emerging Markets Equity Income Fund (AEF), MFS Multimarket Income Trust (MMT), and The Mexico Fund (MXF). These companies are all part of the "financial services" industry. PhenixFIN vs. Abrdn Life Sciences Investors BlackRock MuniYield Michigan Quality Fund Liberty All-Star Growth Fund Saratoga Investment BlackRock MuniHoldings New York Quality Fund MFS Intermediate Income Trust TriplePoint Venture Growth BDC Abrdn Emerging Markets Equity Income Fund MFS Multimarket Income Trust The Mexico Fund Abrdn Life Sciences Investors (NYSE:HQL) and PhenixFIN (NYSE:PFX) are both small-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, risk, institutional ownership, valuation, earnings, community ranking and analyst recommendations. Is HQL or PFX more profitable? PhenixFIN has a net margin of 89.07% compared to Abrdn Life Sciences Investors' net margin of 0.00%. PhenixFIN's return on equity of 4.05% beat Abrdn Life Sciences Investors' return on equity.Company Net Margins Return on Equity Return on Assets Abrdn Life Sciences InvestorsN/A N/A N/A PhenixFIN 89.07%4.05%2.52% Is HQL or PFX a better dividend stock? Abrdn Life Sciences Investors pays an annual dividend of $1.86 per share and has a dividend yield of 13.8%. PhenixFIN pays an annual dividend of $0.48 per share and has a dividend yield of 1.0%. PhenixFIN pays out 5.3% of its earnings in the form of a dividend. Do institutionals and insiders hold more shares of HQL or PFX? 32.2% of Abrdn Life Sciences Investors shares are owned by institutional investors. Comparatively, 43.3% of PhenixFIN shares are owned by institutional investors. 10.1% of Abrdn Life Sciences Investors shares are owned by company insiders. Comparatively, 22.4% of PhenixFIN shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more risk & volatility, HQL or PFX? Abrdn Life Sciences Investors has a beta of 0.71, meaning that its share price is 29% less volatile than the S&P 500. Comparatively, PhenixFIN has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Which has higher earnings & valuation, HQL or PFX? PhenixFIN has lower revenue, but higher earnings than Abrdn Life Sciences Investors. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbrdn Life Sciences Investors$86.69M4.26N/AN/AN/APhenixFIN$28.57M3.51$26.92M$9.125.45 Does the MarketBeat Community believe in HQL or PFX? Abrdn Life Sciences Investors received 35 more outperform votes than PhenixFIN when rated by MarketBeat users. Likewise, 68.35% of users gave Abrdn Life Sciences Investors an outperform vote while only 60.61% of users gave PhenixFIN an outperform vote. CompanyUnderperformOutperformAbrdn Life Sciences InvestorsOutperform Votes9568.35% Underperform Votes4431.65% PhenixFINOutperform Votes6060.61% Underperform Votes3939.39% Does the media refer more to HQL or PFX? In the previous week, PhenixFIN had 4 more articles in the media than Abrdn Life Sciences Investors. MarketBeat recorded 4 mentions for PhenixFIN and 0 mentions for Abrdn Life Sciences Investors. PhenixFIN's average media sentiment score of 0.80 beat Abrdn Life Sciences Investors' score of 0.00 indicating that PhenixFIN is being referred to more favorably in the news media. Company Overall Sentiment Abrdn Life Sciences Investors Neutral PhenixFIN Positive SummaryPhenixFIN beats Abrdn Life Sciences Investors on 8 of the 14 factors compared between the two stocks. Ad ProsperityPubThis Indicator called BOTH NVDA ralliesRarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is… Click this link here. Get PhenixFIN News Delivered to You Automatically Sign up to receive the latest news and ratings for PFX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PFX vs. The Competition Export to ExcelMetricPhenixFIN IndustryFinance SectorNYSE ExchangeMarket Cap$100.38M$2.12B$11.29B$19.19BDividend YieldN/A14.39%5.64%3.62%P/E Ratio5.1610.7326.6941.30Price / Sales3.51151.1035.0617.58Price / Cash17.5113.6618.7321.28Price / Book0.711.882.615.32Net Income$26.92M$57.19M$1.04B$989.88M7 Day Performance3.76%-1.97%-2.91%-3.54%1 Month Performance7.14%-1.62%-3.48%-4.73%1 Year Performance26.96%8.75%10.96%11.57% PhenixFIN Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PFXPhenixFINN/A$49.70+0.6%N/A+29.9%$100.38M$28.57M5.167Insider TradeNews CoverageHQLAbrdn Life Sciences InvestorsN/A$13.84flatN/A+3.0%$378.52MN/A0.00N/AMIYBlackRock MuniYield Michigan Quality FundN/A$11.67+0.2%N/A-0.4%$342.69M$18.58M0.00N/AASGLiberty All-Star Growth FundN/A$5.85+0.3%N/A+7.9%$340.69M$37.15M0.00N/APositive NewsSARSaratoga Investment1.6514 of 5 stars$24.21+0.5%$25.42+5.0%-6.7%$334.10M$143.72M15.743,211News CoverageMHNBlackRock MuniHoldings New York Quality FundN/A$10.66+0.1%N/A-2.9%$322.36MN/A0.00N/AMINMFS Intermediate Income TrustN/A$2.71flatN/A-4.3%$308.40MN/A0.00N/AEx-DividendTPVGTriplePoint Venture Growth BDC0.9697 of 5 stars$7.23-7.9%$7.70+6.5%-31.9%$289.55M$24.23M34.76N/AHigh Trading VolumeAEFAbrdn Emerging Markets Equity Income FundN/A$5.45-0.4%N/A+4.7%$276.60M$26.30M0.00N/AMMTMFS Multimarket Income TrustN/A$4.72-0.4%N/A+1.3%$261.03M$20.10M0.00N/AEx-DividendPositive NewsMXFThe Mexico FundN/A$13.98-0.8%N/A-27.2%$260.07M$35.10M0.00N/ADividend AnnouncementNews Coverage Related Companies and Tools Related Companies HQL Alternatives MIY Alternatives ASG Alternatives SAR Alternatives MHN Alternatives MIN Alternatives TPVG Alternatives AEF Alternatives MMT Alternatives MXF Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:PFX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PhenixFIN Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share PhenixFIN With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PFX Stock Alerts